CompletedNot Applicable

Tranexamic Acid for the Latarjet Procedure.

Ireland100 participantsStarted 2018-03-01

Plain-language summary

The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure. The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • Anterior shoulder instability, warranting the Latarjet procedure Exclusion Criteria: * Patients with known risk factors for hyper-coagulable state * Patients under 16 * Patients unable to give consent to partake in the trial

What they're measuring

Hematoma Formation

Timeframe: Postoperative day-1

Visual Analogue Scale

Timeframe: Postoperative day-1

Total Drain output

Timeframe: Postoperative day-1

Opioid consumption

Timeframe: Postoperative day-1

Trial details

NCT IDNCT03458468

SponsorSports Surgery Clinic, Santry, Dublin

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-03-01

View on ClinicalTrials.gov More Anterior Shoulder Instability trials